Treating B-cell malignancies continues to present many challenges to the biomedical community.
It is the responsibility of researchers and physicians to examine the most up-to-date information
on unique therapies for these disorders in an effort to develop and integrate such strategies into
clinical practice. With this in mind, we are pleased to invite you to the Augmenting Clinical Responses
through Intracellular Pathways in B-cell Malignancies, a satellite symposium to precede the 51st American
Society of Hematology Annual Meeting.
The symposium will cover topics such as treating chronic lymphocytic leukemia vs using a watch and wait
approach, the use of monoclonal antibodies and novel targeted agents in lymphomas, and discussions of
signaling pathways in mantle cell lymphoma and multiple myeloma. A distinguished faculty of national and
international experts will share their experiences and look forward to discussing your questions and ideas.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the
Accreditation Council for Continuing Medical Education through the joint sponsorship of Dannemiller and
Hemedicus, Inc. Dannemiller is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit
Dannemiller designates this activity for a maximum of 3 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
(Back to Meetings)
